
Crystal Growth & Design Journal - ACS Publications
Crystal Growth & Design has been certified as a transformative journal by cOAlition S, committing to a transition to 100% open access in the future. If your research funder has signed Plan S, your open access charges may be covered by your funder through December 31, 2024. Please visit the ACS Open Science website for more information.
CRYSTAL GROWTH & DESIGN_影响因子(IF)_中科院分区_SCI期刊 …
Apr 4, 2025 · Crystal Growth & Design旨在促进从事晶体生长、晶体工程和晶体材料工业应用领域的科学家和工程师之间知识的交叉融合。 该期刊收录与晶体材料设计、生长和应用有关的物理、化学和生物现象及过程的理论及实验研究。 本期刊鼓励采用来自不同学科、技术,并整合晶体生长、晶体工程、分子间相互作用和工业应用领域的协同方法。 同时,期刊还着重强调晶体生长基本概念的提出,并支持进一步理解晶体生长条件与晶体所产生的特性(例如晶体形状、导电性、溶解 …
X-linked carriers of chronic granulomatous disease: Illness ...
Background: Chronic granulomatous disease (CGD) is characterized by recurrent life-threatening bacterial and fungal infections and aberrant inflammation. Mutations in CYBB cause X-linked CGD and account for 65% to 70% of cases in Western countries.
慢性肉芽肿病临床及早期诊断分析 - 中华儿科杂志
慢性肉芽肿病(chronic granulomatous disease,CGD)是我国原发性免疫缺陷病中常见的类型之一,是由烟酰胺腺嘌呤二核苷酸磷酸(nicotinamide-adenine dinucleotide phosphate,NADPH)氧化酶复合物缺陷导致超氧化物的合成下降,从而引起以NADPH酶阳性菌感染及肉芽肿性炎症为主要 ...
Chronic Granulomatous Disease - GeneReviews® - NCBI Bookshelf
Aug 9, 2012 · Chronic granulomatous disease (CGD) is a primary immunodeficiency disorder of phagocytes (neutrophils, monocytes, macrophages, and eosinophils) resulting from impaired killing of bacteria and fungi.
X-linked carriers of chronic granulomatous disease: Illness ...
Jan 1, 2018 · Chronic granulomatous disease (CGD) is characterized by recurrent life-threatening bacterial and fungal infections and aberrant inflammation. Mutations in CYBB cause X-linked CGD and account for 65% to 70% of cases in Western countries. We sought to understand the clinical manifestations associated with the X-linked CGD carrier state.
Chronic granulomatous disease: Clinical, functional, molecular, and ...
Oct 4, 2016 · Chronic granulomatous disease (CGD) is an innate immunodeficiency with a genetic defect of the nicotinamide adenosine dinucleotide phosphate, reduced, oxidase components. This leads to decreased reactive oxygen species (ROS) production, which renders patients susceptible to life‐threatening infections.
Recent advances in chronic granulomatous disease
Mar 1, 2020 · Chronic granulomatous disease (CGD) is an inherited defect of phagocyte function due to defective NADPH oxidase. Patients with CGD are not able to effectively clear the infections because of the defect in the phagocyte production of oxygen free radicals and are prone to recurrent bacterial and fungal infections.
Chronic Granulomatous Disease - Hematology/Oncology Clinics
Nov 26, 2012 · Chronic granulomatous disease (CGD) is a single gene defect that can be reconstituted in vitro and does not require complete correction to be effective, as proven by the normal lives of many X-linked carriers, and by the stable chimeras generated in …
Chronic Granulomatous Disease - PubMed
Apr 21, 2022 · CGD is characterized by severe recurrent bacterial and fungal infections and dysregulated inflammatory responses resulting in granuloma formation and other inflammatory disorders such as colitis. Infections typically involve the lung (pneumonia), lymph nodes (lymphadenitis), liver (abscess), bone (osteomyelitis), and skin (abscesses or cellulitis).